162 related articles for article (PubMed ID: 24639337)
1. Restrictive lung involvement in facioscapulohumeral muscular dystrophy.
Scully MA; Eichinger KJ; Donlin-Smith CM; Tawil R; Statland JM
Muscle Nerve; 2014 Nov; 50(5):739-43. PubMed ID: 24639337
[TBL] [Abstract][Full Text] [Related]
2. FSHD1 and FSHD2 form a disease continuum.
Sacconi S; Briand-Suleau A; Gros M; Baudoin C; Lemmers RJLF; Rondeau S; Lagha N; Nigumann P; Cambieri C; Puma A; Chapon F; Stojkovic T; Vial C; Bouhour F; Cao M; Pegoraro E; Petiot P; Behin A; Marc B; Eymard B; Echaniz-Laguna A; Laforet P; Salviati L; Jeanpierre M; Cristofari G; van der Maarel SM
Neurology; 2019 May; 92(19):e2273-e2285. PubMed ID: 30979860
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of facioscapulohumeral muscular dystrophy 2.
de Greef JC; Lemmers RJ; Camaño P; Day JW; Sacconi S; Dunand M; van Engelen BG; Kiuru-Enari S; Padberg GW; Rosa AL; Desnuelle C; Spuler S; Tarnopolsky M; Venance SL; Frants RR; van der Maarel SM; Tawil R
Neurology; 2010 Oct; 75(17):1548-54. PubMed ID: 20975055
[TBL] [Abstract][Full Text] [Related]
4. [Facioscapulohumeral muscular dystrophy type 2].
Sacconi S; Desnuelle C
Rev Neurol (Paris); 2013; 169(8-9):564-72. PubMed ID: 23969240
[TBL] [Abstract][Full Text] [Related]
5. Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy.
Moreira S; Wood L; Smith D; Marini-Bettolo C; Guglieri M; McMacken G; Bailey G; Mayhew A; Muni-Lofra R; Eglon G; Williams M; Straub V; Lochmüller H; Evangelista T
J Neurol; 2017 Jun; 264(6):1271-1280. PubMed ID: 28550484
[TBL] [Abstract][Full Text] [Related]
6. Leg Muscle Involvement in Facioscapulohumeral Muscular Dystrophy: Comparison between Facioscapulohumeral Muscular Dystrophy Types 1 and 2.
Mair D; Huegens-Penzel M; Kress W; Roth C; Ferbert A
Eur Neurol; 2017; 77(1-2):32-39. PubMed ID: 27855411
[TBL] [Abstract][Full Text] [Related]
7. Facioscapulohumeral muscular dystrophy 1 patients participating in the UK FSHD registry can be subdivided into 4 patterns of self-reported symptoms.
Banerji CRS; Cammish P; Evangelista T; Zammit PS; Straub V; Marini-Bettolo C
Neuromuscul Disord; 2020 Apr; 30(4):315-328. PubMed ID: 32327287
[TBL] [Abstract][Full Text] [Related]
8. Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging.
Giacomucci G; Monforte M; Diaz-Manera J; Mul K; Fernandez Torrón R; Maggi L; Marini Bettolo C; Dahlqvist JR; Haberlova J; Camaño P; Gros M; Tartaglione T; Cristiano L; Gerevini S; Calandra P; Deidda G; Giardina E; Sacconi S; Straub V; Vissing J; Van Engelen B; Ricci E; Tasca G
Eur J Neurol; 2020 Dec; 27(12):2604-2615. PubMed ID: 32697863
[TBL] [Abstract][Full Text] [Related]
9. Best practice guidelines on genetic diagnostics of facioscapulohumeral muscular dystrophy: Update of the 2012 guidelines.
Giardina E; Camaño P; Burton-Jones S; Ravenscroft G; Henning F; Magdinier F; van der Stoep N; van der Vliet PJ; Bernard R; Tomaselli PJ; Davis MR; Nishino I; Oflazer P; Race V; Vishnu VY; Williams V; Sobreira CFR; van der Maarel SM; Moore SA; Voermans NC; Lemmers RJLF
Clin Genet; 2024 Jul; 106(1):13-26. PubMed ID: 38685133
[TBL] [Abstract][Full Text] [Related]
10. MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.
Andersen G; Dahlqvist JR; Vissing CR; Heje K; Thomsen C; Vissing J
J Neurol; 2017 Mar; 264(3):438-447. PubMed ID: 28000006
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and molecular diagnosis of facioscapulohumeral dystrophy type 1 (FSHD1) in 2012].
Salort-Campana E; Nguyen K; Lévy N; Pouget J; Attarian S
Rev Neurol (Paris); 2013; 169(8-9):573-82. PubMed ID: 24011979
[TBL] [Abstract][Full Text] [Related]
12. Exome sequencing identifies a novel SMCHD1 mutation in facioscapulohumeral muscular dystrophy 2.
Mitsuhashi S; Boyden SE; Estrella EA; Jones TI; Rahimov F; Yu TW; Darras BT; Amato AA; Folkerth RD; Jones PL; Kunkel LM; Kang PB
Neuromuscul Disord; 2013 Dec; 23(12):975-80. PubMed ID: 24128691
[TBL] [Abstract][Full Text] [Related]
13. Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing.
Jones TI; Yan C; Sapp PC; McKenna-Yasek D; Kang PB; Quinn C; Salameh JS; King OD; Jones PL
Clin Epigenetics; 2014; 6(1):23. PubMed ID: 25400706
[TBL] [Abstract][Full Text] [Related]
14. The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1.
Sacconi S; Lemmers RJ; Balog J; van der Vliet PJ; Lahaut P; van Nieuwenhuizen MP; Straasheijm KR; Debipersad RD; Vos-Versteeg M; Salviati L; Casarin A; Pegoraro E; Tawil R; Bakker E; Tapscott SJ; Desnuelle C; van der Maarel SM
Am J Hum Genet; 2013 Oct; 93(4):744-51. PubMed ID: 24075187
[TBL] [Abstract][Full Text] [Related]
15. Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations.
Voermans NC; van der Bilt RC; IJspeert J; Hogrel JY; Jeanpierre M; Behin A; Laforet P; Stojkovic T; van Engelen BG; Padberg GW; Sacconi S; Lemmers RJLF; van der Maarel SM; Eymard B; Bassez G
J Neurol; 2019 Dec; 266(12):2987-2996. PubMed ID: 31471688
[TBL] [Abstract][Full Text] [Related]
16. Respiratory pattern in a FSHD pediatric population.
Trucco F; Pedemonte M; Fiorillo C; Tacchetti P; Brisca G; Bruno C; Minetti C
Respir Med; 2016 Oct; 119():78-80. PubMed ID: 27692152
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of respiratory function in facioscapulohumeral muscular dystrophy.
Teeselink S; Vincenten SCC; Voermans NC; Groothuis JT; Doorduin J; Wijkstra PJ; Horlings CGC; van Engelen BGM; Mul K
J Neurol; 2022 Jul; 269(7):3682-3689. PubMed ID: 35147730
[TBL] [Abstract][Full Text] [Related]
18. Milder phenotype in facioscapulohumeral dystrophy with 7-10 residual D4Z4 repeats.
Statland JM; Donlin-Smith CM; Tapscott SJ; Lemmers RJ; van der Maarel SM; Tawil R
Neurology; 2015 Dec; 85(24):2147-50. PubMed ID: 26561289
[TBL] [Abstract][Full Text] [Related]
19. A complex interplay of genetic and epigenetic events leads to abnormal expression of the DUX4 gene in facioscapulohumeral muscular dystrophy.
Gatica LV; Rosa AL
Neuromuscul Disord; 2016 Dec; 26(12):844-852. PubMed ID: 27816329
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory facioscapulohumeral muscular dystrophy type 2 in 18p deletion syndrome.
Renard D; Taieb G; Garibaldi M; Maues De Paula A; Bernard R; Lagha N; Cristofari G; Vovan C; Chaix C; Lévy N; Khau Van Kien P; Sacconi S
Am J Med Genet A; 2018 Aug; 176(8):1760-1763. PubMed ID: 30055030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
